Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Nexstim Plc Terminates Market Making Agreement with Pareto Securities AB in Nasdaq First North Finland

Nexstim Oyj
Posted on: 25 Aug 16

Company announcement, Helsinki, 25 August 2016, at 9:00 am

Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company with a pioneering navigated non-invasive brain stimulation system, has decided to terminate its market making agreement with Pareto Securities AB in Nasdaq First North Finland market.

Nexstim Plc has given notice of terminating the market making agreement between Nexstim Plc and Pareto Securities AB in Nasdaq First North Finland. Termination will be effective on 25 October 2016. The market making agreement already in place with Pareto Securities AB in Nasdaq First North Sweden market will continue until further notice.

Martin Jamieson, Chairman & CEO

Further information is available on the website or by contacting:

Nexstim                                                                +447715163942
Martin Jamieson, Chairman & CEO
UB Securities Oy (Certified Adviser)              +358 (0)9 2538 0246

Consilium Strategic Communications           +44 (0)20 3709 5700
Mary-Jane Elliott / Ivar Milligan / Laura Thornton

About Nexstim Plc
Nexstim is a medical technology company which has pioneered its technology in brain diagnostics with the Navigated Brain Stimulation (NBS) system as the first and only FDA-cleared and CE-marked navigated Transcranial Magnetic Stimulation (nTMS) system for pre-surgical mapping of the motor and speech cortices. Based on the same technology platform, the company has developed a system called Navigated Brain Therapy (NBT®) which is CE-marked for chronic neuropathic pain, major depression and stroke therapy. Nexstim's shares are listed on Nasdaq First North Finland and Nasdaq First North Sweden. For more information please visit

Nexstim Plc Terminates Market Making Agreement

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Nexstim Oyj via GlobeNewswire

Last updated on: 26/08/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.